Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Dununu.com Dununu

Sponsor

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

RSS Feed Business

Posted

96

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!

'Do not travel': US issues level 4 advisory for Israel as tension escalates

By 0 3

RBI's new regulation? Issues draft norms on Rupee interest rate derivatives; allows non-resident to undertake transactions

The Reserve Bank of India has released draft regulations to update rules for Rupee Interest Rate...

By 0 32

'Don't want to be where I was a couple of years ago': Karun Nair

Karun Nair, poised for an India Test team return after eight years, reflects on a challenging...

By 0 35

Aruna didn't have kids with Kuku as she was his second wife

Veteran actress Aruna Irani opened up about her marriage to filmmaker Kuku Kohli and her past...

By 0 39

Meera shocked by sudden passing of Mannara’s father

In a heartbreaking development, Mannara Chopra, who recently shot to fame with her participation...

By 0 48